Volume 4, Issue 3, September 2023

					View Volume 4, Issue 3, September 2023
  • Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-Positive Patients
  • Psoriasiform and Eczematous Paradoxical Reactions to Biologic Agents
  • Use of Neuromodulators as Aesthetic Treatment in the Lower Face
  • A Practical Guide to Non-insured Health Benefits (NIHB) for Dermatologists Caring for Status First Nations and Inuit Peoples of Canada
  • Strategies to Optimize Outcomes and Prevent Complications with Lasers
Published: 2023-09-29